Pursuant to subsection D of § 54.1-3443, the Board of Pharmacy is giving notice of a public hearing to consider placement of chemical substances in Schedule I of the Drug Control Act. The virtual public hearing will be conducted at 9:05 a.m. on September 6, 2022. Instructions will be included in the agenda for the board meeting, also on September 6th. Public comment may also be submitted electronically or in writing prior to September 6th to Caroline Juran, Executive Director of the Board of Pharmacy to caroline.juran@dhp.virginia.gov.
Pursuant to article § 54.1-3443(D), The Virginia Department of Forensic Science (DFS) has identified five (5) compounds for recommended inclusion into Schedule I of the Drug Control Act.
The following compound is classified as a synthetic opioid. Compounds of this type have been placed in Schedule I (§ 54.1-3446(1)) in previous legislative sessions.
Based on their chemical structures, the following compounds are expected to have hallucinogenic properties. Compounds of this type have been placed in Schedule I (§ 54.1-3446(3)) in previous legislative sessions.
Based on its chemical structure, the following compound is expected to have depressant properties. Compounds of this type have been placed in Schedule I (§ 54.1-3446(4)) in previous legislative sessions.
The following compounds are classified as cannabimimetic agents. Compounds of this type have been placed in Schedule I (§ 54.1-3446(6)) in previous legislative sessions.
Name / Title: | Caroline Juran, RPh / Executive Director |
Address: |
9960 Mayland Drive Suite 300 Henrico, 23233 |
Email Address: | caroline.juran@dhp.virginia.gov |
Telephone: | (804)367-4456 FAX: (804)527-4472 TDD: ()- |